0001479290-23-000102.txt : 20230907
0001479290-23-000102.hdr.sgml : 20230907
20230907173742
ACCESSION NUMBER: 0001479290-23-000102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230905
FILED AS OF DATE: 20230907
DATE AS OF CHANGE: 20230907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moxie Dwight
CENTRAL INDEX KEY: 0001803375
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 231243184
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BOULEVARD
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1222 DEMONBREUN STREET
STREET 2: SUITE 2000
CITY: NASHVILLE
STATE: TN
ZIP: 37203
BUSINESS PHONE: 6157247755
MAIL ADDRESS:
STREET 1: 1222 DEMONBREUN STREET
STREET 2: SUITE 2000
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
wf-form4_169412261597584.xml
FORM 4
X0508
4
2023-09-05
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001803375
Moxie Dwight
C/O REVANCE THERAPEUTICS, INC
1222 DEMONBREUN STREET, 20TH FLOOR
NASHVILLE
TN
37203
0
1
0
0
SVP, GC & Secretary
1
Common Stock
2023-09-05
4
S
0
23853
17.8141
D
55066
D
Common Stock
2023-09-06
4
S
0
11000
17.064
D
44066
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated June 05, 2023 by Mr. Moxie.
The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.44 to $18.20. Mr. Moxie undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.80 to $17.52. Mr. Moxie undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Dwight Moxie
2023-09-07